Podcasts about MBC

Featuring perspectives from Prof Giuseppe Curigliano, Prof Nadia Harbeck, Dr Ian E Krop, Dr Nancy U Lin and Dr Joyce O'Shaughnessy, including the following topics:  Introduction (0:00) Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer — Prof Harbeck (1:39) Case: A woman in her mid 50s presents with locally advanced ER-positive, HER2-positive breast cancer — Alan B Astrow, MD (12:52) Case: A woman in her mid 40s with ER-positive, HER2-positive Stage II breast cancer s/p neoadjuvant TCHP with residual disease receives adjuvant T-DM1 but discontinues due to neuropathy — Laila Agrawal, MD (20:02) Previously Untreated HER2-Positive Metastatic Breast Cancer (mBC) — Prof Curigliano (25:10) Case: A woman in her early 80s presents with de novo metastatic (bone-only) ER-positive, HER2-positive breast cancer — Zanetta S Lamar, MD (35:03) Optimal Management of Brain Metastases in Patients with HER2-Positive Breast Cancer — Dr Lin (46:20) Case: A woman in her early 60s with ER-positive, HER2-positive breast cancer develops a cerebellar metastasis while receiving adjuvant anastrozole after prior anti-HER2 therapy — Justin Favaro, MD, PhD (59:41) Case: A woman in her early 40s with ER-negative, HER2-positive mBC develops a headache shortly after neoadjuvant TCHP, surgery and postneoadjuvant T-DM1 and is found to have an isolated 4-cm brain metastasis — Dr Agrawal (1:05:36) Selection and Sequencing of Therapy for Relapsed/Refractory HER2-Positive mBC in the Absence of CNS Involvement — Dr Krop (1:12:00) Case: A woman in her early 40s with ER-positive, HER2-positive mBC receives THP (docetaxel/trastuzumab/pertuzumab) and maintenance tucatinib with trastuzumab/pertuzumab on a clinical trial and now has disease progression — Yanjun Ma, MD, PhD (1:23:04) Tolerability Considerations with HER2-Targeted Therapies — Dr O'Shaughnessy (1:29:32) Case: A woman in her mid 60s presents with localized ER-negative, HER2-positive infiltrating ductal carcinoma — Erik Rupard, MD (1:46:06) Case: A woman in her early 70s with recurrent ER-positive, HER2-positive mBC receives trastuzumab deruxtecan (T-DXd) and has concerning pulmonary symptoms but without findings on diagnostic imaging — Kimberly Ku, MD Case: A woman in her mid 40s with ER-positive, HER2-positive breast cancer metastatic to the brain and lung who received multiple prior treatments responds to T-DXd but develops Grade 1 interstitial lung disease — Richard Zelkowitz, MD (1:49:49) CME information and select publications

Featuring perspectives from Dr Javier Cortés, Dr Rita Nanda, Prof Peter Schmid and Dr Priyanka Sharma, including the following topics:  Introduction (0:00) Case: A woman in her early 80s with multiple comorbidities and triple-negative breast cancer (TNBC) develops bone-only metastases 4 months after declining capecitabine for post-neoadjuvant residual disease — Justin Favaro, MD, PhD (1:50) Case: A woman in her mid 70s with ER-negative, HER2-low (IHC 1+), PIK3CA-mutated, PD-L1-positive metastatic breast cancer (mBC) after receiving 3 cycles of neoadjuvant paclitaxel/carboplatin/pembrolizumab, which was discontinued — Alan Astrow, MD (6:47) Previously Untreated Metastatic TNBC (mTNBC) — Prof Schmid (10:47)  Case: A woman in her early 80s with multiregimen-recurrent ER-positive, HER2-low (IHC 1+) ESR1-mutant mBC receives sacituzumab govitecan — Jennifer Yannucci, MD (27:19) Case: The role of datopotamab deruxtecan (Dato-DXd) for patients with ER-positive, HER2-low mBC who experienced disease progression on prior trastuzumab deruxtecan (T-DXd) — Ranju Gupta, MD; Case: A woman in her late 70s with bilateral recurrence in the lungs of ER-negative, HER2-low (IHC 1+) breast cancer (PD-L1 TPS 20%) receives Dato-DXd with durvalumab on protocol — Yanjun Ma, MD, PhD (31:35) Integrating Antibody-Drug Conjugates (ADCs) into the Management of Endocrine-Resistant Hormone Receptor-Positive mBC — Dr Sharma (36:31) Case: A woman in her early 70s with recurrent ER-negative, HER2-low (IHC 2+) mBC receives sacituzumab govitecan and achieves complete remission — Dr Gupta; Case: Management of neutropenia associated with sacituzumab govitecan — Gigi Chen, MD (50:30) Case: A woman in her late 60s with recurrent ER-negative, HER2-low (IHC 1+) mBC (HER2 V69L mutation) receives T-DXd and achieves a complete response but develops Grade 1 interstitial lung disease — Dr Gupta; Case: Management of T-DXd-related side effects — Laila Agrawal, MD (54:10) Selection and Sequencing of Therapy for Relapsed/Refractory mTNBC — Dr Nanda (58:59) Case: A woman in her early 40s with multiregimen-recurrent ER-positive, HER2-low mBC who has experienced severe nausea with past treatments is about to initiate T-DXd — Atif M Hussein, MD, MMM (1:12:40) Tolerability and Other Practical Considerations with ADCs and Other Cytotoxic Agents for mBC — Dr Cortés (1:18:10) CME information and select publications

1-2부 [뉴스신세계] 1. 한동훈, 당무감사 결과에 "동명이인" 2. 경찰 ‘강선우 1억 수수' 수사 착수 3. 김병기 갑질 의혹 10건 공공범죄수사대로 - 현영준 MBC 기자 (출연) [이슈하이킥1] 경제 사령탑에 이혜훈, 대통령의 속내는? - 이규연 청와대 홍보소통수석 (출연)

1-2부 [뉴스신세계] 1. 이혜훈 기획예산처 장관 후보자...국민의힘 '제명' 2. 김건희 특검, 수사 결과 발표 3. 李대통령 청와대 첫 출근 - 현영준 MBC 기자 (출연) [이슈하이킥1] 김건희 특검 마무리…남은 의혹은? - 김용민 더불어민주당 의원 (출연)

1-2부 [뉴스신세계] 1. 초유의 정부 패싱…쿠팡 ‘셀프조사' 논란 2. 尹 첫 구형 징역 10년 "중대범죄 책임" 3. 김병기, 계속되는 의혹 폭로...내용은? - 이정은 MBC 기자 (출연) [이슈하이킥] 특별조사국 폐지…감사국 개혁 방안은 - 김인회 전 감사원장 권한대행 (출연)

1-2부 [뉴스신세계] 1. 3천쪽 통일교 내부문건에 드러난 로비 정황 2. 김병기, ‘숙박권' 의혹 이어 가족 의전 논란 3. '설계자' 노상원의 계엄 실패 수습 계획 - 이정은 MBC 기자 (출연) [거침없이하이킥] 한동훈-장동혁, 화해할 수 있을까? - 신인규 변호사 - 장성철 공론센터 소장 (출연)

1-2부 [뉴스신세계] 1. '허위·조작정보 유통 금지' 국회 본회의 통과 2. 김용현·여인형 추가 구속…증거인멸 우려 3. 김병기, 호텔 숙박권 이어 '가족 의전‘ 의혹 - 현영준 MBC 기자 (출연) [이슈하이킥1] 통일교 특검, 추천권 놓고 힘겨루기 - 이동형 작가 (출연)

Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics:  Overview: Molecular basis of antibody-drug conjugate (ADC) toxicities — Sequencing of ADCs and mechanisms of resistance (0:00) Case: A woman in her late 60s with localized triple-negative breast cancer develops myocarditis during neoadjuvant therapy with chemotherapy/pembrolizumab — Richard Zelkowitz, MD (8:22) Case: A woman in her mid 70s with recurrent ER-negative, HER2-low, PD-L1-positive metastatic breast cancer (mBC) who experiences disease progression on nab paclitaxel/atezolizumab responds to sacituzumab govitecan — Ranju Gupta, MD (26:43) Case: A woman in her early 80s with recurrent ER-positive, HER2-low (IHC 1+) mBC experiences disease progression on trastuzumab deruxtecan (T-DXd), then receives datopotamab deruxtecan and develops pulmonary symptoms — Laila Agrawal, MD (32:11) Data Review: T-DXd (37:51) Case: A woman in her early 70s with recurrent ER-positive, HER2-low (IHC 1+) mBC, including bladder metastases, experiences disease progression after palbociclib/letrozole, then capivasertib/fulvestrant, then nab paclitaxel — Justin Favaro, MD, PhD (44:02) Case: A woman in her late 70s with ER-positive, HER2-low mBC who experiences disease progression after 1 year of ribociclib/letrozole receives sacituzumab govitecan — Erik Rupard, MD (55:19) CME information and select publications

1-2부 [뉴스신세계] 1. 민주당, '통일교 특검' 전격 수용 2. ‘내란재판부법' 본회의 상정, 필버 나선 장동혁 3. 특검, ‘로저비비에' 김기현 피의자 소환 - 현영준 MBC 기자 (출연) [이슈 하이킥1] 與, ‘내란재판부법' 본회의 상정…입장은? - 신장식 조국혁신당 수석 최고위원 (출연)

1-2부 [뉴스신세계] 1. 국민의힘, 윤리위원장 인선 난항 2. 與, 대법 예규에도 내란재판부법 처리 방침 3. 전재수, 경찰청 출석 "불법 금품수수 없다" - 이정은 MBC 기자 (출연) [이슈하이킥] “외교부가 대북정책 주도해선 안돼” - 정세현 전 통일부장관 (출연)

1-2부 [뉴스신세계] 1. 대법원, ‘국가적 중요사건 전담재판부' 설치 2. 윤영호-한학자 녹취록 "이재명 됐으면 작살났다" 3. 장동혁vs한동훈…국민의힘 내홍 계속 - 이정은 MBC 기자 (출연) [거침없이하이킥] 업무보고·통일교 의혹·내란전담재판부, 향후 정국은? - 신인규 변호사 - 장성철 공론센터 소장 (출연)

1-2부 [뉴스신세계] 1. 김건희 특검, ‘로저비비에' 김기현 전방위 압수수색 2. 장동혁 “국힘, 당명 개정 필요하다면 검토” 3. 국회 쿠팡 청문회...김범석 불출석 - 현영준 MBC 기자 (출연) [이슈하이킥1] 업무보고 생중계, 누구의 아이디어? - 이규연 대통령실 홍보소통수석 (출연)

In this educational, refreshing, and beautifully hopeful episode, Wren, the creator of the Living Our Breast Lives Podcast, is joined by the incredible Metastatic Breast Cancer Thriver, Carolyn Leigh, the President of North Star Cancer Advocacy.In 2018, she was the third member of her family to be diagnosed with metastatic breast cancer, including her mother and uncle. After her metastatic diagnosis, she spent years studying the latest scientific understandings about the immune system and immunotherapies for cancer before launching North Star Cancer Advocacy in 2022 with the aim of providing information to the community and advocating for vast increases in NIH funding. The North Star Board of Directors and the MBC community recently raised $100k to further the research of combining Natural Killer cells (immune system cells) and one of the most promising breast cancer drugs in preclinical development, ErSO-TFPy.In this episode, join me as Carolyn breaks down: - How the inspirational Judy Perkins and TILs therapy reshaped her belief in what's possible- The moment she decided to found North Star- A simple breakdown of MHC I expression and why some immunotherapies succeed while others don't- A crash course in how immunotherapy actually works inside the body- Her mission to raise six figures for immunotherapy-driven clinical trials — and what real success would look like - How and where to access immunotherapy clinical trials- A raw conversation about allyship, momentum, and why the MBC movement can't depend solely on those living with the diseaseCarolyn isn't just an MBC advocate… she's a brilliant mind, a fierce researcher, the president of the North Star Cancer Research Foundation, and a woman determined to change the future of metastatic breast cancer!Living Our Breast Lives Information:Email: livingourbreastlivespodcast1@gmail.comInstagram: @livingourbreastlivesFounder: Wren MorrobelPersonal Instagram: @wren_morrPodcast Guest Speaker: Carolyn Leigh's Information:Email: NorthStarCancerAdvocacy@yahoo.comInstagram: @north.star.cancer.advocacy@north.star.cancer.researchFacebook: North Star Cancer Research FoundationWebsite: NorthStarCancerResearch.orgCRI Clinical Trial Finder:https://cri.careboxhealth.com/en-US/

1-2부 [뉴스신세계] 1. 내란 특검, 수사 결과 발표 2. 국수본, 통일교 전방위 강제수사 3. 쿠팡 김범석 “청문회 바빠서 못간다” - 현영준 MBC 기자 (출연) [이슈하이킥1] 특검, 조희대·지귀연 무혐의…입장은? - 김용민 더불어민주당 의원 (출연)

1-2부 [뉴스신세계] 1. 통일교 '정교유착' 파문 계속 2. 박성재, 안가회동에 '계엄 자료' 들고 갔다 3. 쿠팡, 美 로비 4년간 1000만불 - 이정은 MBC 기자 (출연) [이슈하이킥] 탄핵 1년, 내란 선고는 0건 - 서영교 더불어민주당 의원 (출연)

1-2부 [뉴스신세계] 1. ‘통일교 의혹' 전재수 사의 2. 특검, 박성재 내란혐의로 기소 3. 오늘부터 임시국회, 여야 ‘필버' 대치 - 이정은 MBC 기자 (출연) [거침없이하이킥] 통일교 의혹, 정치권 파장은? - 김지호 더불어민주당 대변인 - 장성철 공론센터 소장 (출연)

1-2부 [뉴스신세계] 1. 尹-추경호, 계엄 직후 통화…"오래 안 갈 거니 걱정 말라" 2. 전재수 장관, 통일교 금품 수수 의혹…"사실무근" 3. 당무감사위, 한동훈 가족 실명 공개 논란 - 현영준 MBC 기자 (출연) [주간정치동형] 통일교 금품 수수 의혹, 정치권 파장은? - 이동형 작가 (출연)

Join this program for relevant updates across the advanced and metastatic breast cancer (mBC) spectrum as presented in October 2025. Credit available for this activity expires: 12/8/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/hot-topics-berlin-2025-what-experts-say-about-future-2025a1000x8r?ecd=bdc_podcast_libsyn_mscpedu

1-2부 [뉴스신세계] 1. 與 내란재판부 의총…결론 못내 2. 도이치 공범 "김건희 알았을 것" 3. 오늘부터 청와대 이전 시작 - MBC 현영준 기자 (출연) [이슈하이킥1] ‘내란재판부법' 연내 처리될까? - 이건태 더불어민주당 의원 (출연)

[뉴스신세계] 1. 민주당 '1인 1표제' 부결 2. 출범 6개월 만에 자중지란 빠진 국민의힘 3. 사법개혁 앞두고 전국법원장회의 - MBC 이정은 기자(출연) [이슈하이킥] '2025 결산 특집' 사법개혁 어디까지 왔나? - 더불어민주당 김용민 의원(출연)

[뉴스신세계] 0. 뉴스하이킥 '李정부 6개월 여론조사'...결과는? 1. 내란전담재판부법 법사위 통과...곧 본회의 상정 2. '15년 구형' 김건희의 남은 혐의들은? 3. '인사청탁 문자 논란' 김남국 사퇴 - MBC 이정은 기자(출연) [거침없이하이킥] 국힘 초재선 25인 '계엄 사과'…집단행동 더 이어지나? - 신인규 변호사 - 공론센터 장성철 소장(출연)

[이슈하이킥] 이재명정부 6개월 여론조사...민심의 향방은? - MBC 장슬기 기자 - 케이스탯리서치 원성훈 부사장 (출연) [이슈하이킥2] '계엄 사과' 두고 내부 갈등...국힘 어디로? - 국민의힘 양향자 최고위원 (출연)

1-2부 [뉴스신세계] 1. 유진그룹 YTN 인수 승인 취소 2. 해병특검 150일 수사 마무리 3. ‘패트' 국힘 26명 중 21명 항소 - MBC 이정은 기자 (출연) [이슈하이킥] 검찰, 대장동 이어 패트도 항소 포기? - 박범계 더불어민주당 의원 (출연)

1-2부 [뉴스신세계] 1. 檢, ‘패트' 1심 항소 포기 2. “김건희가 거짓 진술 부탁“ 폭로 3. 추경호 체포동의안 가결…국힘 불참 - MBC 이정은 기자 (출연) [거침없이하이킥] “우리라도 사과” vs “내부 분열”…우왕좌왕 국힘 - 신인규 변호사 - 장성철 공론센터 소장 (출연)

1-2부 [뉴스신세계] 1. 내란특검, 한덕수에 징역 15년 구형 [미니인터뷰] -박은정 조국혁신당 의원 (전화) 2. 李, 검사 집단 퇴정에 "엄정 감찰·수사" 지시 3. 김건희 "김혜경·김정숙 수사는?" - MBC 현영준 기자 (출연) [이슈하이킥1] 트럼프 2기, 우리에게 필요한 외교는? - 문정인 연세대 석좌교수 (출연)

In this special Vision Sunday message, Pastors Dave and Bob lead MBC into a milestone season—our 175th anniversary year—celebrating God's faithfulness in the past and clarifying His calling for the future. Through Scripture, stories, and a powerful relay-race illustration, we are reminded that every generation must faithfully pass the baton of the Gospel.Together, we unveil major initiatives for 2026 and beyond: expanding parking to welcome more people, building a prayer garden, strengthening discipleship pathways, resourcing the next generation, partnering globally with missionaries in Senegal and Romania, expanding local outreach to the VA and City Relief, launching Summerfest, and stepping into a new disability ministry—Upside Down Glory.Now we unite around the vision God has given our church:Firmly Planted. Growing Together. Made to Multiply.

1-2부 [뉴스신세계] 1. 여인형 "계엄 무릎 꿇고 말려" 2. 검사 161명 집단 사표…10년새 최다 3. 종묘 앞 개발…한호건설이 독식? - MBC 현영준 기자 (출연) [이슈하이킥1] 조국 VS 장동혁 토론, 언제·어떻게? - 신장식 조국혁신당 의원 (출연)

Mama Bear Care walks with Mamas carrying to term despite a prenatal life-limiting diagnosis. This show tells the stories of three moms, including Barbara Jacobson and her daughter Verity. With fierce love and tender care, MBC changes stories from heartache to hope.” www.mamabearcare.org/See omnystudio.com/listener for privacy information.

1-2부 [뉴스신세계] 1. 공수처, 지귀연 첫 압수수색 2. '도이치 공범' 오늘 구속영장 청구 3. 해병특검, 윤석열 등 12명 기소 - MBC 현영준 기자 (출연) [이슈하이킥] 종묘 경관의 미래는? - 김진애 국가건축정책위원장 (출연)

1-2부 [뉴스신세계] 1. 나경원 1심 벌금형, 핵심내용은? 2. 신안 여객선 좌초, 운항 과실 판단 3. 김민석 “한동훈, 잘했다"…국힘은 '조용' - MBC 현영준 기자 (출연) [거침없이하이킥] 론스타 승소, 한동훈 존재감 커질까? - 신인규 변호사 - 장성철 공론센터 소장 (출연)

Send us a textToday's episode tackles a topic that is often misunderstood, palliative care. Many people hear the term and immediately think of end-of-life care but that's not what palliative care is. In reality, it's about improving quality of life, managing symptoms, and helping you live as fully and comfortably as possible, no matter where you are in your metastatic breast cancer (MBC) treatment.We're joined by Dr. Jones, a palliative care physician who has worked closely with people living with MBC. He brings not only medical expertise, but also deep compassion and insight into the emotional and physical needs of our community.In this conversation, we explore:What palliative care truly meansHow to access palliative care servicesWhy integrating palliative care early can make such a meaningful differenceWhether you're newly diagnosed or have been living with MBC for many years, this episode offers clarity, reassurance, and practical information to support you on your journey.Visit OurMBCLife.org for episode notes.

Featuring a slide presentation and related discussion from Dr Erika Hamilton, including the following topics: Mechanisms of endocrine resistance; incidence of ESR1 mutations in breast cancer (0:00) Testing methods for ESR1 mutations in patients with breast cancer; therapeutic options for patients with ESR1-mutant breast cancer (3:59) General overview of proteolysis-targeting chimeras (PROTACs); comparison of PROTAC estrogen receptor (ER) degraders and selective ER degraders (7:39) Early-phase data with vepdegestrant monotherapy or in combination with CDK4/6 inhibitors in ER-positive, HER2-negative metastatic breast cancer (mBC) (11:54) Phase III VERITAC-2 trial of vepdegestrant versus fulvestrant in ER-positive, HER2-negative mBC previously treated with endocrine therapy and a CDK4/6 inhibitor (17:48) Ongoing clinical trials evaluating vepdegestrant in novel combinations or treatment settings; other clinical applications of PROTACs (26:08) CME information and select publications

1-2부 [뉴스신세계] 1. 한·UAE 정상회담…AI·방산 협력 강화 2. '피고인석 김건희' 두 달만…5분여 중계 3. 론스타 승소에 한동훈 “숟가락 치워” - MBC 현영준 기자 (출연) [이슈하이킥1] ‘항소 포기' 논란, 대통령실 입장은? - 이규연 대통령실 홍보소통수석 (출연)

1부 [JB TIMES] 종묘·한강버스 이어 광화문까지..金총리, 吳와 연일 ‘각' 한덕수 재판서 추경호 “증언 거부”·최상목 “계엄 만류” 前소방청장, 이상민 ‘MBC 등에 단전단수 지시' 증언 김미나 “시체팔이 족속은 민주당”에 민주 “사퇴하라” 경찰, 여고 앞 '소녀상 철거' 시위에 첫 금지 통고 - 더 막내작가

1-2부 [뉴스신세계] 1. ‘집단 반발' 검사장→평검사 전보 검토 2. 김건희 오빠, 19일 구속기로 3. 유네스코, 종묘 앞 개발에 ‘강력 조치' 요구 - MBC 현영준 기자 (출연) [이슈하이킥1] ‘집단 반발' 검사, 징계 가능성은? - 더불어민주당 김용민 의원 (출연)

Brian Noonan, Wally Podrazik, Justin Kulovsek and Chris Pokorny (the museum exhibit team) join WGN Radio's (and MBC chair, president and CEO) Dave Plier to talk about the new exhibits at the Museum of Broadcast Communications: “Johnny Carson: The Centennial,” “The Evolution of Late Night,” Antenna TV's “I Dream of Jeannie” 65th anniversary, “Bozo's Circus” […]

Featuring slide presentations and related discussion from Prof Francois-Clement Bidard, Dr Hope S Rugo, Dr Rebecca Shatsky and Dr Seth Wander, including the following topics: Optimal approach to biomarker testing for patients with ER-positive metastatic breast cancer (mBC) (0:00) Case: A woman in her early 70s with recurrent ER-positive, HER2-negative mBC receives elacestrant (15:15) Case: A woman in her early 60s with ER-positive, HER2-low, PIK3CA-mutated mBC receives inavolisib-based therapy and experiences no disease progression for 24 months (18:02) Role of oral selective estrogen receptor degrader (SERD) monotherapy in the treatment of progressive ER-positive, HER2-negative mBC (26:26) Case: A woman in her mid 60s with recurrent HR-positive, HER2-negative mBC receives elacestrant (44:12) Case: A woman in her early 50s with recurrent HR-positive, HER2-negative, PIK3CA-mutant mBC receives capivasertib and fulvestrant (45:33) Potential novel applications of oral SERDs in the management of ER-positive, HER2-negative breast cancer (51:25) Case: A woman in her mid 50s with recurrent ER-positive, HER2-negative, PIK3CA-mutated mBC experiences disease progression 18 months after starting first-line letrozole and ribociclib (1:03:46) Case: A woman in her mid 50s with ER-positive, HER2-negative breast cancer undergoes serial ctDNA monitoring during first-line therapy (1:06:54) Tolerability and other practical considerations with oral SERDs (1:14:30) Case: A woman in her early 60s with recurrent HR-positive, HER2-negative mBC receives elacestrant (1:33:26) Case: A woman in her early 60s with recurrent HR-positive, HER2-negative mBC receives elacestrant (1:37:38) CME information and select publications

1-2부 [뉴스신세계] 1. 李대통령, 팩트시트 합의 직접 발표 2. 황교안-박성재 구속영장 모두 기각 3. 노만석, 퇴임사서 “검사 징계 논의 멈춰달라” - MBC 이정은 기자 (출연) [이슈하이킥] 검찰 출신이 보는 ‘항소 포기' 논란 - 조국혁신당 박은정 의원 (출연)

1-2부 [뉴스신세계] 1. 장동혁 "우리가 황교안" 발언 후폭풍 2. 윤석열, 내란재판서 홍장원과 대면 3. 김윤덕·오세훈 회동…서울 집값 안정 논의 - MBC 이정은 기자 (출연) [주간정치동형] ‘항소 포기' 거센 후폭풍, 정국 어디로? - 이동형 작가 (출연)

1-2부 [뉴스신세계] - MBC 현영준 기자 (출연) [이슈하이킥1] ‘검사징계법' 손보나? - 더불어민주당 전현희 의원 (출연)

Send us a textOur annual “We Remember” episode honors all who died from metastatic breast cancer since last October and gives voice to the grief and love that endures after each death. Each name shared is a tiny marker of a full & beloved life and each one leaves behind an expansive network of loved ones. For those of us in the MBC community, the loss of our friends is particularly devastating & the cumulative losses are heavy. You are not alone in your grief. We invite you to gather with us to honor the individual lives lost in the last year, and to acknowledge and provide space for the grief we collectively feel.Please visit OurMBCLife.org to see the full episode notes.

[장경태 더불어민주당 의원]최민희 논란? 국감 파행 자극적 기사에 항의언론 적 만든다? 개혁 과정의 성장통김민수 발언? 中 자본 국내 투자 2% 뿐 부동산 정책, 공급 확대 방안 힘 실어야 [김종혁 국민의힘 前 최고위원]MBC, 막장 국감 비판한 것 뿐...최민희 논란尹 몰락 시작점, '바이든-날리면' 보도 공방외국인 투자, 美 돈은 괜찮고 中은 안되나?이상경, 국민 염장 그만 지르고 사퇴해야 ■ 방송 : CBS 라디오 [김현정의 뉴스쇼] FM 98.1 (07:10~09:00)■ 진행 : 김현정 앵커■ 대담 : 장경태(더불어민주당 의원), 김종혁(국민의힘 前 최고위원)See omnystudio.com/listener for privacy information.

Janice Cowden, retired nurse and patient advocate, shares her remarkable triple negative breast cancer (TNBC) story. Five years following successful treatment for stage one breast cancer in 2011, Janice was diagnosed with a stage 4 metastatic TNBC recurrence. As of today she has 8 years of no evidence of disease (NED) under her belt. She shares how she stumbled upon the cancer community that inspired her to become the advocate she is today and the uncertainty that comes with NED. She also shares how she copes with losing friends in the cancer community through her patient advocacy work. We also have a rapid fire Q&A where she answers questions surrounding various medical terminologies, diagnoses, and more to keep you in the loop. NOTE: There is one clarification from the rapid fire Q&A session. The definition of disease free survival (DFS) is the time from random assignment (used in clinical trials and research studies to assign participants to different groups) to cancer recurrence or death from any cause (Gutman SI, Piper M, Grant MD, et al. 2013).Key Highlights:1. Metastatic breast cancer (MBC) is stage four breast cancer that has spread to distant sites in the body.2. Finding events and communities centered around cancer not only supports cancer patients emotionally and socially, but can also serve as informational hubs. Being proactive in learning about your diagnosis, whether it's through community and/or research on your own time, can help you feel confident with the choices you make. 3. While finding a community of other cancer patients can help, unfortunately this disease means that you will lose friends you make in these settings. It doesn't necessarily get easier, but finding an outlet to cope with such losses is vital to your wellbeing.About our guest:Diagnosed with Stage IV triple negative breast cancer in 2016, five years after an early-stage breast cancer diagnosis, Janice launched into patient advocacy following training through Living Beyond Breast Cancer's (LBBC) Hear My Voice Outreach program in 2017. As a peer-to-peer support and research patient advocate, Janice is passionate about supporting others with metastatic breast cancer, in addition to continually furthering her scientific knowledge base of this disease, treatments, and clinical trials, which she acquires through attending scientific breast cancer conferences and webinars. Janice is involved with several patient-founded and led organizations including PCDI, GRASP, and Project Life MBC. As a trained peer support volunteer, she is founder of an international online peer support group for patients newly diagnosed with MBC. She serves on the Board of Directors for METAvivor Research and Support Inc., and is an Advisory Board member for Project Life MBC. She is an individual member of the Metastatic Breast Cancer Alliance. When she's not busy with advocacy work, Janice enjoys traveling, reading, outdoor activities, and spending time with family, including her husband, two adult children and three grandchildren.Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions.

◎ 1부 [뉴스 연구소] 부동산 민심, 사과한 민주당/ 캄보디아 로맨스 스캠 부부, 대사관이 풀어줬다/ 딴지일보에 글 쓴 정청래 경향신문 박순봉 기자, 김준일 시사 평론가 [월간] 김건희, ‘용상’ 착석 논란/ 김현지, 국감 불출석?/ 최민희, MBC보도본부장 퇴장 지시/ 이상영 1차관, 발언 논란 더불어민주당 박지원 의원 ◎ 2부 [놓지마 뉴스] 방송인 강승희 [인터뷰 (1)] 사법·검찰·언론 3대 개혁안 평가/ 尹 면회 찾아간 장동혁 조갑제 조갑제닷컴 대표 [인터뷰 (2)] 10만 전자, 50만 닉스/ 2차 전지 주가 급등/ 금값은 폭락, 왜? AFW파트너스 이선엽 대표 [미니 댓꿀쇼] 지방선거 판세 분석 조갑제 조갑제닷컴 대표 See omnystudio.com/listener for privacy information.

How do you know if your child is making progress in therapy? What if therapy came with a GPS that showed you exactly where your child is on their mental health journey and the best route to reach their goals? In this episode, we explore measurement-based care (MBC) with CHC experts Pardis Khosravi, PsyD and Emily Hsu, PhD – about this approach that's transforming mental health treatment by making progress visible and treatment more effective.Join us as we break down this game-changing practice that combines regular progress tracking with personalized care. We'll discover why MBC matters for everyone – not just clinicians – and how simple questionnaires and check-ins can dramatically improve the therapy experience.Resources:CHC OnlineCHC's Catherine T. Harvey Center for Clinical ServicesCHC's Resource LibrarySign up for our Virtual Village email list to receive our latest episodes and recent CHC updates. Visit Voices of Compassion online for full show notes including additional resources. Find us on Facebook, Twitter, Instagram and LinkedIn and visit our YouTube channel for videos. Subscribe and leave us a review wherever you listen! We love to hear from you - email us at podcast@chconline.org.Santo Rico by Twin Musicom is licensed under a Creative Commons Attribution 4.0 license. https://creativecommons.org/licenses/by/4.0/Artist: http://www.twinmusicom.org/

[고민사연] 안녕하세요? MBC 라디오 미니로 손경제 청취하는 40대 직장인입니다. 올해 이직해서 근무 중인데 회사 사정 상 폐업을 한다는 얘기를 들었습니다. 이직한지 1년이 안되었는데, 회사가 없어지면 퇴직금을 받을 수 있는건가요.? 회사가 문을 닫게되면 어디로 가서 어떻게 퇴직금을 달라고 해야하는지도 궁금합니다. 참고로, 저희 회사는 증권사에 DB형 퇴직연금이 가입되어 있고, 폐업은 연내에 이뤄질 것 같다고 합니다. 회사 폐업도 걱정이긴 하지만, 다시 이직할 일도 걱정입니다.

Featuring perspectives from Dr Aditya Bardia and Dr Adam M Brufsky, including the following topics: Introduction: Antibody-drug conjugates in localized breast cancer (0:00) Case: A frail woman in her late 70s with ER-positive, HER2-low metastatic breast cancer (mBC) receives sacituzumab govitecan after multiple lines of therapy — Eric Fox, DO (7:46) Case: A woman in her early 60s with NTRK-mutant ER-negative, HER2-low recurrent mBC receives trastuzumab deruxtecan — Lai (Amber) Xu, MD, PhD (21:07) Case: A woman in her mid 70s with PIK3CA-mutant recurrent metastatic triple-negative breast cancer who developed a diverticular abscess on neoadjuvant chemoimmunotherapy receives sacituzumab govitecan and pembrolizumab — Alan B Astrow, MD (31:49) Case: A woman in her mid 60s with ER-negative, HER2-low mBC receives sacituzumab govitecan after experiencing disease progression on capecitabine — Laila Agrawal, MD (38:37) Case: A woman in her late 50s with ER-negative, HER2-low mBC receives trastuzumab deruxtecan after experiencing disease progression on sacituzumab govitecan — Kimberly Ku, MD (44:24) Case: A woman in her early 60s with ER-positive, HER2-low mBC and hyperglycemia receives trastuzumab deruxtecan after experiencing disease progression on capivasertib/fulvestrant — Eleonora Teplinsky, MD (48:50) CME information and select publications

In this raw, funny, and beautifully honest episode, Wren, the founder of the Living Our Breast Lives Podcast, is joined by the vibrant Annie Bond—a woman who's not just living with Metastatic Breast Cancer, but marking an incredible 10 years of thriving with it. Annie invites us beyond the diagnosis and into her world: her advocacy, her comedy, her social media voice, and her unapologetic authenticity.We dive into the realities of MBC—from the milestone of a decade with the disease to the heartbreak of a recent breakup and painful losses we experience so often in this community. Annie shares how she uses dark humor and creativity to cope, how advocacy keeps her grounded, and why building authentic connections—online and in person—has been one of the greatest gifts of this journey.She also opens up about the balance between laughter and grief, joy and sorrow, and why honesty matters more than toxic positivity ever could. Through it all, Annie reminds us that even in the hardest spaces, community and truth-telling can carry us forward.Whether you're living with MBC, love someone who is, or just want to hear a bold and unfiltered story of resilience, humor, and heart—this episode is for you. It's real, it's raw, and it's proof that even in the face of stage four, life can still be loud, messy, meaningful—and full of laughter.Living Our Breast Lives Information:Email: livingourbreastlivespodcast1@gmail.comInstagram: @livingourbreastlivesFounder: Wren MorrobelPersonal Instagram: @wren_morrAnnie Bond's Information:@theanniebond on FB, IG, and TikTok

Send us a textIn our Season 11 opening episode, we're bringing you the latest updates from the 2025 ASCO Annual Meeting on metastatic breast cancer. Dr. Ashley Schreier, breast oncologist at Weill Cornell Medicine, breaks down key research and explains what it could mean for people living with MBC.Topics include:Research results for hormone therapy options like camizestrantThe role of ESR1 mutation testingResults from treatment combinations like Enhertu and Perjeta, and Trodelvy and KeytrudaHow to navigate clinical trial accessTips for staying hopeful while exploring treatment optionsWhether you're a patient, caregiver, or advocate, this episode is packed with insights to help you stay informed and empowered.

Today, we welcome Tami Eagle Bowling — motivational speaker and advocate for #LightUpMBC, a global event illuminating landmarks and amplifying patient voices. The program has raised hope and more than $2 million for metastatic breast cancer research.Here are links to #LightUpMBC resources:www.lightupmbc.orghttps://www.instagram.com/lightupmbc/https://www.instagram.com/metavivor/After 20 years in media sales leadership at Condé Nast and Hearst, holding roles like Associate Publisher of Marie Claire and Teen Vogue, Tami's life changed at 41 when she was diagnosed de novo with Stage IV metastatic breast cancer while raising two young children.She transformed her energy into advocacy, creating #LightUpMBC LIVE, She also co-produces The Janice Jam, Broadway for Breast Cancer, and has been featured on Good Morning America, The Today Show, and beyond. She's here to share her journey of resilience, advocacy, and creativity.From Publishing to Purpose: Tami, you spent two decades leading in the media world. Can you share what skills and experiences from that career you drew upon when shifting your energy into advocacy and creating #LightUpMBC LIVE?The Power of Visibility: Close to 300 landmarks across 166+ cities around the world will be illuminated on Metastatic Breast Cancer Awareness Day on October 13 as part of the incredible global campaign. How are landmark owners joining the #LightUpMBC campaign by lighting in the symbolic MBC colors of green, teal and pink on October 13? Why is visibility — literally lighting up the world — such a powerful metaphor and tool for raising awareness and hope in the MBC community?Patient Voices & Advocacy: You've said your mission is to amplify patient voices. What are some of the most important stories and lessons you've witnessed through the livestreams and advocacy work that you think the wider world needs to hear?Survive and Thrive: You've been honored with awards and legislative recognition for your impact. But beyond the spotlight, what does “survive and thrive” mean to you personally, as a mother, a patient, and a leader?The Eagle Method: You've created The Eagle Method as a framework to build resilience, embrace uncertainty, and improve mental health. Can you walk us through what it is, and how you apply it in your own life and with others?Tami, what's one piece of advice you would share with someone facing uncertainty or adversity about finding their voice and turning it into something that helps others?Connect with Tami at Tami's Website , and @EagleMethod on Instagram Thanks to our sponsor, White Cloud Coffee, fueling creative conversations everywhere. Listeners, enjoy 10% off your first order at whitecloudcoffee.com.And before you go, don't forget to download your free e-book of Your World of Creativity when you visit mark-stinson.com.